Nektar TherapeuticsNKTRNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-6.53
↑ 76% vs avg
Percentile
P64
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-27.16
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -6.53 | -126.8% |
| 2024 | -2.88 | -268.5% |
| 2023 | -0.78 | +45.7% |
| 2022 | -1.44 | +74.4% |
| 2021 | -5.62 | +25.8% |
| 2020 | -7.58 | +29.1% |
| 2019 | -10.69 | -231.4% |
| 2018 | 8.13 | +103.6% |
| 2017 | -224.68 | -1049.4% |
| 2016 | -19.55 | - |